Mechanisms of drug interactions with urinary elimination of lithium;Mécanisme des interactions médicamenteuses avec l'élimination rénale du lithium

Bulletin de l'Academie Nationale de Medecine

Volumn 181, Issue 4, 1997, Pages 685-697

  Imbs, Jean Louis ^a,b   Barthelmebs, Mariette ^a,b   Danion, Jean Marie ^a,c   Singer, Léonard ^a,c   Ardaillou, M Raymond ^d  

^a Roche Inst de Pharmacologie Clin   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c UNIVERSITY HOSPITAL OF STRASBOURG   (France)

^d NONE

Author keywords

Antiinflammatory agents, non steroidal; Bradikinin; Drug interactions; Kidney, drug effects; Lithium, urine; Prostaglandins; Receptors, angiotensin, antagonists and inhibitors

Indexed keywords

LITHIUM;

ANIMAL; ARTICLE; DRUG INTERACTION; KIDNEY; MALE; METABOLISM; RAT; URINE; WISTAR RAT;

ANIMALS; DRUG INTERACTIONS; KIDNEY; LITHIUM; MALE; RATS; RATS, WISTAR;

EID: 2542499116     PISSN: 00014079     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. SINGER L., IMBS J.L., SCHMIDT M. et al. - Baisse de la clairance rénale du lithium sur l'effet de la phénylbutazone. L'Encéphale, 1978, 4, 33-40.
2. DANION J.M., SCHMIDT M., WELSCH M. Interaction entre les anti-inflammatoires non-stéroïdiens et les sels de lithium. L'Encéphale, 1987, 13, 255-260.
3. BARTHELMEBS M., DANION J.M., GRIMA M.., KRIEGER J.P., MASSARI C., IMBS J.L. - Differential effects of aspirin and indomethacin on sodium and lithium handling by the isolated perfused rat kidney. Lithium, 1992, 3, 125-132.
4. IMBS J.L., DANION J.M., SCHMIDT M., WELSCH M., SINGER L. - Lithium therapy : non-steroïdal anti-inflammatory drugs. In Lithium Therapy Monographs, Ed. F. Neil Johnson. - Basel : Karger Pub., 1987, vol. 1, pp. 201-216.
5. DANION J.M., SCHMIDT M., IMBS J.L., SINGER L., SCHWARTZ J. - Benoxaprofen has no influence on the urinary elimination of lithium. Contr Nephrol, 1984, 42, 248-252.
6. IMBS J.L., SINGER L., DANION J.M., SCHMIDT M., ZAWILSLAK R. - Effects of indomethacin and methylprednisolone on renal elimination of lithium in the rat. Int Pharmacopsychiat, 1980, 15, 143-149.
7. BARTHELMEBS M., DECKER N., DANION J.M., STEPHAN D., WELSCH M., IMBS J.L. - The effects of sulindac and its active metabolite, desoxysulindac, on renal lithium excretion in the rat. Lithium, 1992, 3, 35-42.
8. EDOU D., GODIN M., COLONNA L. - Interaction médicamenteuse : clométacine-lithium. Presse Med, 1983, 12, 1551.
9. WIENER G., SCHOLKENS B.A., BECKER R.H.A., BUSSE R. - Ramiprilat enhances endothelial antocoid formation by inhibiting breakdown of endothelium-derived bradykinin. Hypertension, 1991, 18, 558-563.
10. THOMSEN K. - Lithium clearance : a new method for determining proximal and distal tubular reabsorption of sodium and water. Nephron, 1984, 37, 217-223.
11. BOER W.H., FRANSEN R., BOER P., DE ROOS R., KOOMANS H.A. - Prostaglandin synthesis inhibition stimulates lithium reabsorption in Henle's loop in rat. Kidney International, 1993, 43, 301-306.
12. REGOLI D., BARABE J. - Pharmacology of bradykinin and related kinins. Pharmacological Rev, 1980, 32, 1-46.
13. GRIDER J., FALCONE J., KILPATRICK E., OTT C., JACKSON B. - Effect of bradykinin on NaCl transport in the medullary thick ascending limb of the rat. Eur J Pharmacol, 1995, 287, 101-104.
14. TOMITA K., PISANO J.J., BURG M.B., KNEPPER M.A.. - Effects of vasopressin and bradykinin on anion transport by the rat cortical collecting duct. Evidence for an electroneutral Na+ chloride transport pathway. J. Clin. Invest., 1986, 77, 136-141.
15. LAHERA V., SALOM M.G., FIKSEN-OLSEN M.J., ROMERO J.C. - Mediatory role of endothelium-derived nitric oxide in renal vasodilatory and excretory effects of bradykinin. Am J Hypertens, 1991, 4, 260-262.